期刊文献+

膀胱过度活动的药物治疗进展 被引量:4

Advance in the pharmacologic management of the overactive bladder
在线阅读 下载PDF
导出
摘要 随着对下尿路功能的深入研究 ,膀胱功能障碍的药物治疗也取得了可喜成绩。 Continued developments in the understanding of lower urinary tract function have led to improvements in the pharmacologic manipulation of bladder dysfunction. We herein review new agents and drug delivery systems in the treatment of overactive bladder.
出处 《医学研究生学报》 CAS 2004年第2期167-168,共2页 Journal of Medical Postgraduates
关键词 膀胱过度活动 药物治疗 Overactive bladder Pharmacologic management
  • 相关文献

参考文献12

  • 1[1]Chancellor MB, De Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways that we treat the overactive bladder[J].J Urol ,1999,162(1): 3-11.
  • 2[2]Larsson G, Hallen B, Nilvebrandt L. Tolterodine in the tretment of overative ldder : an analysis of the pooled phase Ⅱefficacy and safety data[J]. Urology,1999,53(5):990-990.
  • 3[3]Gupta SK, Sathyan G. Pharmacokinetics of an oral once a day controlled release oxybutnin formulation compared with immediate release oxybutnin[J]. J Clin Pharmacol,1999,39(3):289-296.
  • 4[4]Chancellor MB, Appell RA , Sathyan G et al. Effect of controlled release oxybutynin and tolterodine on salivary output[J]. Neurourol Urodyn, 2000,19(1):94.
  • 5[5]Frolich G, Burmeister S, Wiedemann A et al. Intravesical trospium chloride , oxybutynin, and verapimil for relaxation of detrusor muscle: placebo controlled, randomized clinical tial in Germany[J]. Arzneimittelforschung,1998,48(4):486-491.
  • 6[6]Rosario DJ, Cutinha PE, Chapple CR et al. The effects of ingle dose darifenicin on cystometric parameters and salivary flow in patients with urge incontinence secondary to detrusor instability[J].Eur Urol,1996,30(3):240.
  • 7[7]Phelan MW, Yoshimura N, Goins WF et al. Nerve growth factor(NGF) gene therapy improves rat diabetic cystopathy, but does not increase pain sensation[J]. J Urol,2000,163(3):245-248.
  • 8[8]Palmer LS, Zebold K, Firlt CF et al. Complications Of intravesical oxybutnin chloride therapy in the peditric myelomeningocele population[J]. J Urol,1997,157(2):638-640.
  • 9[9]Singh SS, Smith KM, Brown DM. Drug retention following intravesical delievery of fluorouracil therapeutic adhesive in C3H mouse bladderc[J]. Anticancer Drugs,1996,7(4):507-511.
  • 10[10]Dasgupta P, Chandiramani V, Parkinson MC et al. Treating the human bladder with capsaicin : isit safe?[J] Eur Urol,1998,33(1):28-32.

二级参考文献12

  • 1Robert ML, Janice H, Alan J. The effect of short-term obstruction on urinary bladder function in the rabbit[J]. J Urol,1984,132:789-791.
  • 2Khan MR, Dashwood CS, Thompson FH, et al. Up-regulation of Endothelin-B receptor(ETB) and ETB receptor-mediated rabbit detrusor contraction in partial bladder outlet obstruction[J].BJU Int,1999, 84.714-719.
  • 3Tejada I, Mueller JD, de Las Morenas A, et al. Endothelin in the urinary bladder 1. Synthesis of endothelin-1 by epithelia、muscle and fibroblasts suggests autocrine and paracrine cellular regulation[J]. J Urol, 1992, 148(4):1290-1298.
  • 4Traish A,Moran E, Krene RJ, et al. Endothelin in the urinary bladder: II Characterization of endothelin receptor subtypes[J]. J Urol,1992, 148(4):1299-1306.
  • 5Yanagisawa M, Kurihara H,Kimura S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J].Nature,1988,332:411.
  • 6Inoue A,Yanagisawa M,Kimura S,et al. The human endothelin family:Three structurally and pharmacologically distinct isopeptides predicted by three separate genes[J].Proc Natl Acad Sci USA, 1989,86:2863-2867.
  • 7Imai T,Hirata Y, Emori T,et al. Induction endothelin-1 gene by angiotansin and vasopressin in endothelial cells[J]. Hypertension, 1992, 19(6pt 2):753-757.
  • 8Le Monner de Gouville AC,Lippton HL, Cavera I, et al. Endothelin-a new family of endothelium-derived peptides with wide spread bioligical properties[J]. Life Sci, 1989, 45(17):1499-1513.
  • 9Langenstroer P, Tang R,Divrsh B, et al. Endothelins in caninegenitourinary tissue[J]. J Urol, 1997, 157(3):1044-1048.
  • 10Lecci A,Giuliani S,Santicioli P, et al. Intracerebroventricular administration of endothelins:effects on the supraspinal micturition reflex and blood pressure in the anaesthetized rat[J]. Eur J Pharmacol, 1991, 199(2):201-207.

共引文献6

同被引文献38

  • 1龚隽,高建平,程文.膀胱出口不全梗阻兔的尿流动力学实验研究[J].医学研究生学报,2005,18(2):185-185. 被引量:2
  • 2金锡御 宋波.临床尿动力学[M].北京:人民卫生出版社,2003.63.
  • 3Verhamme KMC, Dieleman JP, Bleumink GS et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care-The Triumph Project [J]. Eur Urol, 2002, 42(4):323-328.
  • 4Clifford GM, Logie J, Farmer RDT. How do symptoms indicative of BPH progress in real life practice? [J]. UK Exper Eur Urol, 2000, 38(Suppl 1):48-53.
  • 5Machadomg,Yoo JJ,Atala A. Defunctionalized bladders: effects before and after refunctionalization in an animal mode [J]. J Urol, 2000, 164(3 Pt 2): 1002-1007.
  • 6Matsumoto S, Chichester P, Kogan BA et al. Structural and vascular response of normal and obstructed rabbit whole bladders to distension [J]. Urology, 2003 , 62(6):1129-1133.
  • 7van Venrooij GE, Van Melick HH, Eckhardt MD et al. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate [J]. J Urol, 2002, 168(2):605-609.
  • 8Celayir S, Ilce Z, Dervisoglu S. The sex hormone receptors in the bladder in childhood - I: preliminary report in male subjects [J]. Eur J Pediatr Surg, 2002, 12(5):312-317.
  • 9Chou EC, Whitbeck C, Borow A et al. Inhibition of hyperreflexia by vaginally administered oxybutynin: a novel rabbit model [J]. J Urol, 2004,171(2 Pt 1): 958 -962.
  • 10Rouzade-Dominguezml, Pernar L, Beck S et al. Convergent responses of Barrington's nucleus neurons to pelvic visceral stimuli in the rat: a juxtacellular labelling study[J]. Eur J Neurosci, 2003,18(12):3325-3334.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部